A Comparative Analysis of Household Expenditure in Poland and Ukraine von Sydorova Antonina V., Burkina Natalia V., Furman Taras Yu

Volltext

КОМПАРАТИВНИЙ АНАЛІЗ ВИТРАТ ДОМОГОСПОДАРСТВ ПОЛЬЩІ ТА УКРАЇНИ von Sydorova, A V, Burkina, N V, Furman, T Y

Volltext

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome von Legendre, C.M, Licht, C, Muus, P, Greenbaum, L.A, Babu, S, Bedrosian, C, Bingham, C, Cohen, D.J, Delmas, Y, Douglas, K, Eitner, F, Feldkamp, T, Fouque, D, Furman, R.R, Gaber, O, Herthelius, M, Hourmant, M, Karpman, D, Lebranchu, Y, Mariat, C, Menne, J, Moulin, B, Nürnberger, J, Ogawa, M, Remuzzi, G, Richard, T, Sberro-Soussan, R, Severino, B, Sheerin, N.S, Trivelli, A, Zimmerhackl, L.B, Goodship, T, Loirat, C

Volltext

Numerical approximation of 3D particle beams by multi-scale paraxial Vlasov-Maxwell equations von Assous, F., Furman, Y.

Volltext

Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point von Darman, Rachel B., Seiler, Michael, Agrawal, Anant A., Lim, Kian H., Peng, Shouyong, Aird, Daniel, Bailey, Suzanna L., Bhavsar, Erica B., Chan, Betty, Colla, Simona, Corson, Laura, Feala, Jacob, Fekkes, Peter, Ichikawa, Kana, Keaney, Gregg F., Lee, Linda, Kumar, Pavan, Kunii, Kaiko, MacKenzie, Crystal, Matijevic, Mark, Mizui, Yoshiharu, Myint, Khin, Park, Eun Sun, Puyang, Xiaoling, Selvaraj, Anand, Thomas, Michael P., Tsai, Jennifer, Wang, John Y., Warmuth, Markus, Yang, Hui, Zhu, Ping, Garcia-Manero, Guillermo, Furman, Richard R., Yu, Lihua, Smith, Peter G., Buonamici, Silvia

Volltext

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies von Licht, Christoph, Greenbaum, Larry A., Muus, Petra, Babu, Sunil, Bedrosian, Camille L., Cohen, David J., Delmas, Yahsou, Douglas, Kenneth, Furman, Richard R., Gaber, Osama A., Goodship, Timothy, Herthelius, Maria, Hourmant, Maryvonne, Legendre, Christophe M., Remuzzi, Giuseppe, Sheerin, Neil, Trivelli, Antonella, Loirat, Chantal

Volltext

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies von ADVANI, Ranjana H, BUGGY, Joseph J, SUKBUNTHERNG, Juthamas, IZUMI, Raquel, HAMDY, Ahmed, HEDRICK, Eric, FOWLER, Nathan H, SHARMAN, Jeff P, SMITH, Sonali M, BOYD, Thomas E, GRANT, Barbara, KOLIBABA, Kathryn S, FURMAN, Richard R, RODRIGUEZ, Sara, CHANG, Betty Y

Volltext

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity von Cheng, S, Ma, J, Guo, A, Lu, P, Leonard, J P, Coleman, M, Liu, M, Buggy, J J, Furman, R R, Wang, Y L

Volltext

Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study von O'Brien, Susan, Prof, Jones, Jeffrey A, MD, Coutre, Steven E, Prof, Mato, Anthony R, MD, Hillmen, Peter, Prof, Tam, Constantine, MD, Österborg, Anders, Prof, Siddiqi, Tanya, MD, Thirman, Michael J, MD, Furman, Richard R, MD, Ilhan, Osman, Prof, Keating, Michael J, Prof, Call, Timothy G, MD, Brown, Jennifer R, MD, Stevens-Brogan, Michelle, MSc, Li, Yunfeng, PhD, Clow, Fong, ScD, James, Danelle F, MD, Chu, Alvina D, MD, Hallek, Michael, Prof, Stilgenbauer, Stephan, Prof

Volltext

Ibrutinib Resistance in Chronic Lymphocytic Leukemia von Furman, Richard R, Cheng, Shuhua, Lu, Pin, Setty, Menu, Perez, Alexendar R, Guo, Ailin, Racchumi, Joelle, Xu, Guozhou, Wu, Hao, Ma, Jiao, Steggerda, Susanne M, Coleman, Morton, Leslie, Christina, Wang, Y. Lynn

Volltext

Plasmonic Ag nanoparticles via environment-benign atmospheric microplasma electrochemistry von Huang, X Z, Zhong, X X, Lu, Y, Li, Y S, Rider, A E, Furman, S A, Ostrikov, K

Volltext

Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib von Woyach, Jennifer A, Furman, Richard R, Liu, Ta-Ming, Ozer, Hatice Gulcin, Zapatka, Marc, Ruppert, Amy S, Xue, Ling, Li, Daniel Hsieh-Hsin, Steggerda, Susanne M, Versele, Matthias, Dave, Sandeep S, Zhang, Jenny, Yilmaz, Ayse Selen, Jaglowski, Samantha M, Blum, Kristie A, Lozanski, Arletta, Lozanski, Gerard, James, Danelle F, Barrientos, Jacqueline C, Lichter, Peter, Stilgenbauer, Stephan, Buggy, Joseph J, Chang, Betty Y, Johnson, Amy J, Byrd, John C

Volltext

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial von O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof

Volltext

Constraint programming for LNG ship scheduling and inventory management von Goel, V., Slusky, M., van Hoeve, W.-J., Furman, K.C., Shao, Y.

Volltext

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia von Byrd, John C, Furman, Richard R, Coutre, Steven E, Flinn, Ian W, Burger, Jan A, Blum, Kristie A, Grant, Barbara, Sharman, Jeff P, Coleman, Morton, Wierda, William G, Jones, Jeffrey A, Zhao, Weiqiang, Heerema, Nyla A, Johnson, Amy J, Sukbuntherng, Juthamas, Chang, Betty Y, Clow, Fong, Hedrick, Eric, Buggy, Joseph J, James, Danelle F, O'Brien, Susan

Volltext

Targeting an Interaction Between Two Disordered Domains by Using a Designed Peptide von Mayer, Guy, Shpilt, Zohar, Bressler, Shachar, Marcu, Orly, Schueler‐Furman, Ora, Tshuva, Edit Y., Friedler, Assaf

Volltext

Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL von Pastore, Alessandro, Gaiti, Federico, Lu, Sydney X., Brand, Ryan M., Kulm, Scott, Chaligne, Ronan, Gu, Hongcang, Huang, Kevin Y., Stamenova, Elena K., Béguelin, Wendy, Jiang, Yanwen, Schulman, Rafael C., Kim, Kyu-Tae, Alonso, Alicia, Allan, John N., Furman, Richard R., Gnirke, Andreas, Wu, Catherine J., Melnick, Ari M., Meissner, Alexander, Bernstein, Bradley E., Abdel-Wahab, Omar, Landau, Dan A.

Volltext

Targeting an Interaction Between Two Disordered Domains by Using a Designed Peptide von Mayer, Guy, Shpilt, Zohar, Bressler, Shachar, Marcu, Orly, Schueler‐Furman, Ora, Tshuva, Edit Y., Friedler, Assaf

Volltext

Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies von Allan, John N, Pinilla-Ibarz, Javier, Gladstone, Douglas E, Patel, Krish, Sharman, Jeff P, Wierda, William G, Choi, Michael Y, O'Brien, Susan M, Shadman, Mazyar, Davids, Matthew S, Pagel, John M, Yimer, Habte A, Ward, Renee, Acton, Gary, Taverna, Pietro, Combs, Daniel L, Fox, Judith A, Furman, Richard R, Brown, Jennifer R

Volltext

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma von Federico, Sara M, McCarville, M Beth, Shulkin, Barry L, Sondel, Paul M, Hank, Jacquelyn A, Hutson, Paul, Meagher, Michael, Shafer, Aaron, Ng, Catherine Y, Leung, Wing, Janssen, William E, Wu, Jianrong, Mao, Shenghua, Brennan, Rachel C, Santana, Victor M, Pappo, Alberto S, Furman, Wayne L

Volltext